8-K filed May 1, 2026, 7:59 PM ET ticker ORGN CIK 0001802457

other material confidence high sentiment negative materiality 0.95

Origin Materials board approves dissolution, liquidation; CEO steps down; workforce cut 59%

Origin Materials, Inc.

Board approved plan of dissolution and liquidation, subject to stockholder vote at special meeting.
Workforce reduced ~59% (~$14M annual savings); expects ~$2.1M restructuring charges in Q2 2026.
CEO John Bissell steps down effective May 1, 2026; CFO Matt Plavan appointed Interim CEO.
Interim CEO Plavan and General Counsel Joshua Lee receive 25% salary increase and retention bonuses ($183,618 and $153,696).
Company intends to sell technology and assets to maximize shareholder value during wind down.

item 2.05 item 5.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001802457-26-000021
form_type: 8-K
ticker: ORGN
cik: 0001802457
company_name: Origin Materials, Inc.
filed_at: 2026-05-01T23:59:59+00:00
discovered_at: 2026-05-14T18:02:32.933978+00:00
generated_at: 2026-05-15T00:21:19.523080+00:00
sec_items: ["2.05", "5.02", "9.01"]
event_type: other_material
sentiment: negative
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001802457-26-000021
json_url: https://secwatch.observer/filing/0001802457-26-000021.json
markdown_url: https://secwatch.observer/filing/0001802457-26-000021.md
text_url: https://secwatch.observer/filing/0001802457-26-000021.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/orgn-20260501.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

John Bissell

Chief Executive Officer

ORGN · Origin Materials, Inc.

Effective: 2026-05-01
Successor: Matt Plavan
Filed: May 1, 2026, 7:59 PM ET

John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.

Appointed (interim)

Matt Plavan

Interim Chief Executive Officer

ORGN · Origin Materials, Inc.

Effective: 2026-05-01
Filed: May 1, 2026, 7:59 PM ET

Matt Plavan, age 62, our Chief Financial Officer and Chief Operating Officer has been appointed Interim Chief Executive Officer, effective May 1, 2026.

Source-grounded claims

06e0ab8278

John Bissell departed as Chief Executive Officer at Origin Materials, Inc..

John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

c566906b0e

Matt Plavan was appointed as Interim Chief Executive Officer at Origin Materials, Inc..

Matt Plavan, age 62, our Chief Financial Officer and Chief Operating Officer has been appointed Interim Chief Executive Officer, effective May 1, 2026.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

68edfb988c538d8e95a72bf56d701133e8f06b76

Origin Materials, Inc. announced a restructuring with charges of approximately $2.1 million (approximately 59%).

its workforce by approximately 59%, resulting in an approximately $14.0 million decrease in annual operating expenses. Origin anticipates that it will incur approximately $2.1 million in restructuring charges in connection with the workforce reduction, primarily consisting of cash expenditures of approximately $2.1 million for severance and benefits costs.

SEC 8-K Item 2.05/2.06 confidence 0.9 SEC evidence

Comparable filings

LIXT

Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board

LIXTE BIOTECHNOLOGY HOLDINGS, INC. June 1, 2026, 8:55 AM ET other_material Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material similar materiality

This filing

John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.

Comparable filing

On May 29, 2026, the Board of Directors (the “Board”) of Lixte Biotechnology Holdings, Inc., (the “Company”), appointed Stuart D. Porter to serve as a member of the Board, effective May 29, 2026 with a term expiring at the Company’s 2026 Annual Meeting of Stockholders.

Filing page SEC filing

FXAC

FortuneX Acquisition closes IPO of 8.625M units at $10/unit, raising $86.25M gross

FortuneX Acquisition Corp May 29, 2026, 5:32 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material similar materiality

This filing

John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.

Comparable filing

Effective May 19, 2026, in connection with the effectiveness of the Company’s Registration Statement, Becky Fallon, Sean Michael Deegan, and Robert Labbe became members of the board of directors (the “Board”) of the Company.

Filing page SEC filing

CWBHF

Charlotte's Web appoints BAT GC to board, closes debt conversion & US$10M investment

Charlotte's Web Holdings, Inc. June 1, 2026, 5:13 PM ET other_material Items 5.02, 5.07, 8.01

same fact type: executive_change same SEC item: 5.02 same event type: other_material similar materiality

This filing

John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.

Comparable filing

Effective May 28, 2026 (the “Effective Date”), the board of directors of Charlotte’s Web Holdings, Inc. (the “Company”), appoint James Jeffery Raborn to the Company’s board of directors

Filing page SEC filing

DGAC

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material

This filing

John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.

Comparable filing

John W. Heilshorn, Aaron Spool, Michael Faber, John Ziegelman and Jay Gettenberg (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).

Filing page SEC filing

ELOX

Eloxx Pharma: 1-for-11 reverse stock split effective May 29; appoints two independent directors

Eloxx Pharmaceuticals, Inc. June 1, 2026, 7:00 AM ET other_material Items 3.02, 3.03, 5.03, 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material

This filing

John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.

Comparable filing

the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) appointed Stephen W. Webster and Nina Kjellson to fill vacancies on the Board

Filing page SEC filing

FDXF

FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed

FedEx Freight Holding Company, Inc. June 1, 2026, 6:46 AM ET other_material Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 8.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material

This filing

John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.

Comparable filing

each of John A. Smith, R. Brad Martin, Jeffrey A. Davis, Donald E. Frieson, Stephen E. Gorman, Robert A. King, Cindy J. Miller, Amy J. Salcido, and Samantha M. Smith was appointed to the Board

Filing page SEC filing

CRMT

America's Car-Mart forms special committee for strategic alternatives; appoints new independent director

AMERICAS CARMART INC May 29, 2026, 5:30 PM ET other_material Items 1.01, 5.02, 8.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material

This filing

John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.

Comparable filing

On May 22, 2026, the Board increased the size of the Board from nine members to ten members and appointed Adam Paul as an independent director, effective immediately.

Filing page SEC filing

SYRE

Spyre Therapeutics stockholders approve amended ESPP; director Peter Harwin resigns

Spyre Therapeutics, Inc. May 29, 2026, 4:45 PM ET other_material Items 5.02, 5.07, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material

This filing

John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.

Comparable filing

In addition, effective as of May 27, 2026, Peter Harwin resigned from the Board.

Filing page SEC filing

Source: SEC EDGAR

accession 0001802457-26-000021

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.